Cathie Wood’s ARK sells Alphabet stock, buys Freenome shares

On Friday, October 23rd, 2026, the ARK ETF, managed by Cathie Wood, disclosed their daily trading activity. One of the most substantial actions was the sale of 77,167 shares of Alphabet Inc. across their ARKK and ARKW ETFs, equating to $24,752,086. This indicates a strategic shift, given Alphabet's long-standing presence in ARK's portfolio.

Conversely, ARK bolstered its investment in Freenome, Inc. by purchasing 169,498 shares via its ARKG ETF, totaling $2,220,423. This follows a comparable purchase the previous day, suggesting a heightened belief in Freenome's potential. Additionally, the firm offloaded 24,542 shares of Palantir Technologies Inc. across ARKK and ARKW ETFs, amounting to $4,814,894.

This aligns with an earlier trend of diminishing its stake in Palantir. The firm also divested 12,001 shares of Cloudflare, Inc. across ARKK and ARKW ETFs, totaling $3,643,623, which aligns with the overall pattern of reducing exposure to specific tech stocks. Furthermore, ARK sold 42,499 shares of Circle Internet Group, Inc. via its ARKW ETF, valued at $3,681,263.

This sale further exemplifies ARK's strategy of trimming positions in various tech companies. On the acquisition front, ARK continued to increase its position in Pacific Biosciences of California, Inc. by buying 270,693 shares across ARKK and ARKG ETFs, totalling $557,627. This indicates ARK's ongoing interest in the biotech sector.

Lastly, ARK acquired 22,479 shares of Scribe Therapeutics Inc through its ARKG ETF, valued at $403,722, underscoring its commitment to pioneering healthcare solutions. These trades underscore ARK's agile investment approach, striking a balance between divesting from established tech behemoths and bolstering stakes in emerging biotech and healthcare enterprises.